pharmaceutical industry

See the following -

The Best Governance For Medicines ... Is In Thailand

Roy M. Poses | Health Care Renewal | May 23, 2013

Here in the US, a lot of people have been convinced that we have the best health care system in the world... Read More »

The First 3D Printed Organ -- A Liver -- Is Expected In 2014

Lucas Mearian | Computerworld | December 26, 2013

Approximately 18 people die every day waiting for an organ transplant. But that may change someday sooner than you think -- thanks to 3D printing. Read More »

The Growing Trend Of Clinical Research Crowdsourcing

The trend of open collaboration has led to innovation across multiple industries. For decades, big pharma has been known as conservative and slow to change. Today however, there is a growing movement toward open access and crowdsourcing scientific information to accelerate research and development. Open-source platforms have let developers create multiple crowdsourcing applications, that are further enabling the crowdsourcing trend in the life sciences industry, as well.

Read More »

The Holy Grail Of New Drug Development

Rishikesha T. Krishnan | The Hindu Business Line | July 4, 2013

The announcement by Zydus Cadila in early June that their new drug to treat diabetics who also suffer from high cholesterol has passed all stages of clinical trials is an important landmark for the Indian pharmaceutical industry. [...] Read More »

The tranSMART Foundation And BT Collaborate To Deliver Fast, Flexible Cloud-Based Applications To Life Science Organizations

Press Release | tranSMART Foundation, BT | April 30, 2014

BT joins the tranSMART Foundation to extend support to the developer community; companies to continue work on the next release of Translational Medicine Platform.

Read More »

This Is Your Brain On Gluten

James Hamblin | The Atlantic | December 20, 2013

The idea that gluten and carbohydrates are at the root of Alzheimer's disease, anxiety, depression, and ADHD has now reached millions of people. It is the basis of a number-one bestseller written by a respected physician. What is it worth? Read More »

Top 10 eClinical Trends

The drug development industry is facing a revolution in the way clinical trials are being planned and conducted. It’s an industry that experiences rapid changes in technology adoption and business models, from new ways of capturing clinical data to new outsourcing strategies. This paper focuses on ten essential eClinical trends in order to help you understand which direction the biotech industry is prone to take in the next few years. As both the means, and the ultimate motivation of clinical development, patients are the most fundamental assets during the clinical trial process. We have summed up five trends that are destined to give them a more important role in the conduct of clinical studies: Boosting Patient Engagement, Integrated ePRO (electronic Patient Reported Outcomes) Systems, Mobile Clinical Studies, Personalized medicine, and Risk-based monitoring. Read More »

Top 10 Medical Research Trends To Watch In 2013

Margaret Anderson | Huffington Post | January 11, 2013

Congress has pushed the date of the "sequester" off another two months, delaying the prospect of automatic 8.2 percent cuts in the budgets of NIH, FDA, and other federal science programs. But a sequester (or other cuts) could still happen. [...] Read More »

Top Medicare Prescribers Rake In Speaking Fees From Drugmakers

Charles Ornstein, Tracy Weber, and Jennifer LaFleur | ProPublica | June 25, 2013

When the blood pressure drug Bystolic hit the market in 2008, it faced a crowded field of cheap generics. So its maker, Forest Laboratories, launched a promotional assault [...]. It flooded the offices of health professionals with drug reps, and it hired doctors to persuade their peers to choose Bystolic — even though the drug hadn't proved more effective than competitors. Read More »

TPP Treaty Could be a Serious Threat to US Public Health System

While trade agreements may seem to be another, albeit international species of wonkery, these agreements could have major effects on patients' and the public's health.  Since these concerns have been essentially ignored by the US medical and health care literature, (although they have appeared in UK journals, Australian, and New Zealand journals in English), they I will discuss them below. Worthy of further discussion is the possibility that these potential threats to health care and public health may arise not just from ideological disagreements, but also from health care corporations' increasing capture of government, facilitated by the conflicts of interest generated by the revolving door. Read More »

Transitioning To Open Systems In Drug Discovery

John Wilbanks | FasterCures | October 18, 2013

Bringing the ideas of “open source” into the pharmaceutical process is far from simple. It requires a careful understanding both of the realities of open source as a software development process well as the realities of therapy research, development, and regulatory approval. Read More »

Transparency Life Sciences Launches Indication Finder™ Crowdsourcing Tool For Drug Repurposing

Press Release | Transparency Life Sciences (TLS) | October 24, 2012

Transparency Life Sciences (TLS), the world's first drug development company based on open innovation, today announced the launch of Indication Finder™, a survey-based crowdsourcing tool designed to identify promising new indications for existing drug candidates. Read More »

Trial Designed With Crowd Input Gets FDA Signoff

Marc Iskowitz | MM&M | December 28, 2012

What's been called the first clinical study protocol developed using crowdsourcing methods received the FDA's imprimatur earlier this month. The agency approved Transparency Life Sciences' IND for a clinical trial designed to test a generic blood-pressure medication, ACE inhibitor lisinopril, in patients with relapsing remitting multiple sclerosis. Read More »

U.S. Consumers Pay More For Drugs

David Sell | Philly.com | April 10, 2013

U.S. consumers and taxpayers usually pay more - often much more - than people in other developed nations for brand-name drugs, according to a series of papers published Monday in the journal  Health Affairs. Read More »

WATCH: What Doctors Don't Know About The Drugs They Prescribe

Ben Goldacre | Huffington Post | April 5, 2013

TEDTalks can sometimes portray science in triumphalist tones, with fabulous innovations that are changing the world forever. But the real action in science is often around dirty, messy, angry problems, and my TEDTalk is about the dirtiest I've seen yet. Read More »